Article Information
PubMed
Published By
History
- Received January 4, 2007
- Revision received March 28, 2007
- Accepted April 17, 2007
- First published May 23, 2007.
- Version of record published May 23, 2007.
Copyright & Usage
Copyright © 2007 Society for Neuroscience 0270-6474/07/275615-06$15.00/0
Author Information
- Marcello Solinas 1 , 2 ,
- Maria Scherma 2 , 4 ,
- Liana Fattore 5 ,
- Jessica Stroik 2 ,
- Carrie Wertheim 2 ,
- Gianluigi Tanda 3 ,
- Walter Fratta 4 , and
- Steven R. Goldberg 2
- 1Institut de Biologie et Physiologie Cellulaires, Centre National de la Recherche Scientifique-6187, University of Poitiers, 86022 Poitiers, France,
- 2Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch, and
- 3Psychobiology Section, Medications Discovery Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224,
- 4B. B. Brodie Department of Neuroscience, University of Cagliari, 09024 Cagliari, Italy, and
- 5Institute of Neuroscience, National Research Council, Consiglio Nazionale delle Ricerche Italy, 09024 Cagliari, Italy
- Correspondence should be addressed to Steven R. Goldberg, Preclinical Pharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224. sgoldber{at}intra.nida.nih.gov
Author contributions
Disclosures
- Received January 4, 2007.
- Revision received March 28, 2007.
- Accepted April 17, 2007.
-
This work was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; by the Centre National de la Recherche Scientifique; and by the Italian Ministry of University and Scientific Research (MIUR) and the Centre of Excellence on “Neurobiology of Dependence.” We thank Barbara Tuveri for excellent technical assistance.
- Correspondence should be addressed to Steven R. Goldberg, Preclinical Pharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224. sgoldber{at}intra.nida.nih.gov
Online Impact